Showing results (21-30 of 463) with videos related to
Sort By:
Pageof 47
Neurology|January 14, 2004
COMT inhibitors in Parkinson's disease: can they prevent and/or reverse levodopa-induced motor complications?C Warren Olanow, Fabrizio StocchiMovement Disorders : Official Journal of the Movement Disorder Society|February 8, 2013
Obstacles to the development of a neuroprotective therapy for Parkinson's diseaseFabrizio Stocchi, C Warren OlanowAnnals of Neurology|April 1, 2003
Neuroprotection in Parkinson's disease: clinical trialsFabrizio Stocchi, C Warren OlanowMovement Disorders : Official Journal of the Movement Disorder Society|November 28, 2017
Levodopa: A new look at an old friendC Warren Olanow, Fabrizio StocchiCurrent Topics in Behavioral Neurosciences|May 23, 2014
Clinical and pathological features of Parkinson's diseaseSusanne A Schneider, Jose A ObesoThe Lancet. Neurology|April 22, 2004
Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enoughAnthony E Lang, Jose A ObesoExpert Opinion on Pharmacotherapy|September 21, 2018
Istradefylline for the treatment of Parkinson's disease: is it a promising strategy?Margherita Torti, Laura Vacca, Fabrizio StocchiClinical Interventions in Aging|December 1, 2007
Utility of tolcapone in fluctuating Parkinson's diseaseFabrizio Stocchi, Maria Francesca De PandisExpert Opinion on Pharmacotherapy|August 26, 2016
Advances in dopamine receptor agonists for the treatment of Parkinson's diseaseFabrizio Stocchi, Margherita Torti, Chiara FossatiExpert Opinion on Pharmacotherapy|September 15, 2015
Rasagiline for the treatment of Parkinson's disease: an updateFabrizio Stocchi, Chiara Fossati, Margherita TortiPageof 47